ScoreWhy is Eurobio-Scientific SA ?
1
Flat results in Dec 24
- OPERATING CASH FLOW(Y) Lowest at EUR 38.35 MM
- ROCE(HY) Lowest at 2.27%
- CASH AND EQV(HY) Lowest at EUR 23.07 MM
2
With ROE of 3.30%, it has a Very Expensive valuation with a 1.43 Price to Book Value
- Over the past year, while the stock has generated a return of -6.38%, its profits have fallen by -21.3%
3
Underperformed the market in the last 1 year
- Even though the market (France CAC 40) has generated returns of 8.73% in the last 1 year, the stock has hugely underperformed and has generate negative returns of -6.38% returns
Real-Time Research ReportHow much should you sell?
- All quantity irrespective of whether you are making profits or losses
(If sector exposure > 30%, please use optimiser tool to see which are the best stocks to hold in Pharmaceuticals & Biotechnology)
When to re-enter? - We will constantly monitor the company and review our call based on new data
No Data Found
Quality
Management Risk
Growth
Capital StructureQuality key factors
Factor
Value
Sales Growth (5y)
12.04%
EBIT Growth (5y)
-2.69%
EBIT to Interest (avg)
37.35
Debt to EBITDA (avg)
0.21
Net Debt to Equity (avg)
0.02
Sales to Capital Employed (avg)
0.87
Tax Ratio
36.51%
Dividend Payout Ratio
0
Pledged Shares
0
Institutional Holding
0
ROCE (avg)
50.52%
ROE (avg)
25.42%
ValuationValuation Key Factors 
Factor
Value
P/E Ratio
43
Industry P/E
Price to Book Value
1.43
EV to EBIT
21.29
EV to EBITDA
10.89
EV to Capital Employed
1.43
EV to Sales
1.61
PEG Ratio
NA
Dividend Yield
NA
ROCE (Latest)
6.70%
ROE (Latest)
3.30%
TechnicalsTechnical key factors
Indicator
Weekly
Monthly
MACD
Bearish
Mildly Bearish
RSI
No Signal
No Signal
Bollinger Bands
Bearish
Mildly Bullish
Moving Averages
Bearish (Daily)
KST
Bearish
Mildly Bearish
Dow Theory
Mildly Bullish
No Trend
OBV
Mildly Bullish
No Trend
Technical Indicator Scale: Bearish, Mildly Bearish, Sideways, Mildly Bullish, Bullish Turned 
Financial TrendNot enough Data to analyse Financial Trend
Not enough Data to analyse Financial Trend
Here's what is working for Eurobio-Scientific SA
Net Sales
Highest at EUR 81.29 MM
in the last five periodsMOJO Watch
Near term sales trend is positive
Net Sales (EUR MM)
Debt-Equity Ratio
Lowest at -7.46 %
in the last five Semi-Annual periodsMOJO Watch
The company has been reducing its borrowing as compared to equity capital
Debt-Equity Ratio
Raw Material Cost
Fallen by -6.33% (YoY)
MOJO Watch
The company's ability to pass on the cost of raw materials to customers has improved; this may lead to a rise in profit margin
Raw Material Cost as a percentage of Sales
Depreciation
At EUR 7.25 MM has Grown at 6.35%
period on period (QoQ)MOJO Watch
The expenditure on assets done by the company has gone into productive use which should positively reflect in the future sales
Depreciation (EUR MM)
Here's what is not working for Eurobio-Scientific SA
Operating Cash Flow
Lowest at EUR 38.35 MM
in the last three yearsMOJO Watch
The company's cash revenues from business operations are falling
Operating Cash Flows (EUR MM)
Interest
Highest at EUR 2.56 MM
in the last five periods and Increased by 18.95% (QoQ)MOJO Watch
Rising interest cost signifies increased borrowings
Interest Paid (EUR MM)
Net Profit
Lowest at EUR -0.01 MM
in the last five periodsMOJO Watch
Near term Net Profit trend is negative
Net Profit (EUR MM)
Net Profit
Fallen at -100.28%
Year on Year (YoY)MOJO Watch
Near term Net Profit trend is negative
Net Profit (EUR MM)
EPS
Lowest at EUR -0
in the last five periodsMOJO Watch
Declining profitability; company has created lower earnings for shareholders
EPS (EUR)
Cash and Eqv
Lowest at EUR 23.07 MM
in the last six Semi-Annual periodsMOJO Watch
Short Term liquidity is deteriorating
Cash and Cash Equivalents
InfinHub Market Technologies FZ-LLC, Building-2, Unit 112, Dubai Internet City, Dubai, United Arab Emirates
GET THE MARKETSMOJO APP
Company
Stocks
Portfolio
"Investment in securities markets are subject to market risk. Read all the related documents carefully before investing."
